Press Releases

Telehealth to take Blood-Pressure Monitors Market to $1 Billion by 2010
Date: 22 January 2007

Wellingborough, UK – 22^nd January 2007 – A new report from InMedica analysing the market for home-use digital blood pressure monitors has found the world market to be worth almost $800 million. The gradual ageing of the world population combined with the increasing prevalence of hypertension will provide an increasing potential market for home-use digital blood-pressure monitors. The predicted rise of telehealth will add even greater value to the market. InMedica forecasts that the market will grow at a CAGR of 6.7%, taking it to over $1 billion by 2010.

Automatic upper-arm blood-pressure monitors were found to be the most popular, representing just over half of all monitors sold. The ease of use and consistent results gained from automatic upper-arm monitors have strengthened their position as the physicians’ favourite, particularly in the U.S. where it is common for physicians to recommend patients use a blood-pressure monitor at home after they have been diagnosed with hypertension. With a well maintained blood-pressure monitoring plan, a sufferer can see the results of any lifestyle changes they may implement, or the effect of any prescribed medication, helping them to understand their condition and keep it under control.

An emerging technology trend that will accelerate the uptake of home-use blood-pressure monitors is that of “telehealth.” Telehealth promises to allow patients to transmit detailed information about blood-pressure, glucose levels, weight, temperature or respiration to their health professional and receive real-time feedback on their condition.

Steven Burton, analyst at InMedica and author of the report, “The World Market for Home-Use Digital Blood-Pressure Monitors 2006,” gives an example of telehealth in practice, “A blood-pressure monitor can communicate with a cell phone via a Bluetooth link, thus allowing acquisition and transmission of data, most likely using a web-based application. This would enable doctors to monitor the effects of medication on their patients without them having to visit the health centre and, if necessary, remotely issue new prescriptions. This type of solution will help ease the burden currently facing overstretched healthcare systems by reducing the need for patients to routinely visit the doctor.”

Contacting Us

Jonathan Cassell
Senior Manager, Editorial
jonathan.cassell@ihs.com
Direct: + 1 408 654 1714
Mobile: + 408 921 3754

Or

IHS Media Relations
press@ihs.com
Direct: +1 303 305 8021

About IHS Inc. (www.ihs.com)

IHS (NYSE: IHS) is the leading source of information, insight and analytics in critical areas that shape today’s business landscape. Businesses and governments in more than 165 countries around the globe rely on the comprehensive content, expert independent analysis and flexible delivery methods of IHS to make high-impact decisions and develop strategies with speed and confidence. IHS has been in business since 1959 and became a publicly traded company on the New York Stock Exchange in 2005. Headquartered in Englewood, Colorado, USA, IHS is committed to sustainable, profitable growth and employs more than 6,000 people in 31 countries around the world.

IHS is a registered trademark of IHS Inc. All other company and product names may be trademarks of their respective owners. Copyright © 2013 IHS Inc. All rights reserved.

Related Reports

• Japan
• China
• Twitter